Ophthalmic Drug Sustained Release Research Expert Forum & The Five-Year-Plan Meeting

The Ophthalmic Drug Sustained Release Research Expert Forum & The Five-Year-Plan Meeting, organized by State Key Laboratory, Zhongshan Ophthalmic Center of Sun Yat-sen University was hold in Guangzhou YuXi Academy on Dec.27th, 2014. Ophthalmologists across the country were invited to give an academic presentation and post about the program of The Five-YearPlan progress. Being the subject of ophthalmic Drug Sustained Release undertaking unit, Guangzhou Vesber Biotechnology Co.,Ltd. carried on in-depth discussions with the ophthalmologists.
The meeting was started with the opening speech from Dr.Lin, the chairman of Zhongshan Ophthalmology Center of Sun Yatsen University. Tao He, the chairman of Hangzhou Medical Device Institute described the latest medical devices related knowledge and industry status. The vice president of Wenzhou Medical College, Professor Shen demonstrated an academic speech about the application of triamcinolone acetonide in the eye. Being the core leader in ophthalmology, Dr.Hui gave a lecture about the prevention and treatment of diabetic retinopathy. Dr.Yang from Northwest University, Mr.Wu from Guangzhou G&G Cataract Lens Co.,Ltd and Prof. Xie from Zhongshan Ophthalmology Center of Sun Yat-sen University proceeded with academic lectures and discussion.
The peribulbar drug release system, jointed developed by Zhongshan Ophthalmology Center of Sun Yatsen University and Guangzhou Vesber Biotechnology Co..Ltd. has received high evaluation from all the experts.
The advantage is that it will not destroy the eye ball structure while implantation as well as physical release without changes the medicine property. And the medicine could be complemented through drainage valve. The mould sharp could be changed in order to meet the diseased region demand.